Bevacizumab trials for Metastatic Colorectal Cancer (CRC)

All Bevacizumab trials · All Metastatic Colorectal Cancer (CRC) trials

Phase breakdown

Recruiting trials studying Bevacizumab for Metastatic Colorectal Cancer (CRC)

• 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
  NCT06887218 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
  NCT06825624 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
  NCT07500298 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Bevacizumab for Metastatic Colorectal Cancer (CRC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.